Logo image of CRWD

CROWDSTRIKE HOLDINGS INC - A (CRWD) Stock Fundamental Analysis

NASDAQ:CRWD - Nasdaq - US22788C1053 - Common Stock - Currency: USD

375.62  -4.22 (-1.11%)

After market: 376 +0.38 (+0.1%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CRWD. CRWD was compared to 283 industry peers in the Software industry. While CRWD seems to be doing ok healthwise, there are quite some concerns on its profitability. CRWD is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CRWD was profitable.
CRWD had a positive operating cash flow in the past year.
In the past 5 years CRWD reported 4 times negative net income.
CRWD had a positive operating cash flow in each of the past 5 years.
CRWD Yearly Net Income VS EBIT VS OCF VS FCFCRWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

CRWD has a Return On Assets of -0.22%. This is in the better half of the industry: CRWD outperforms 61.84% of its industry peers.
Looking at the Return On Equity, with a value of -0.59%, CRWD is in the better half of the industry, outperforming 62.54% of the companies in the same industry.
Industry RankSector Rank
ROA -0.22%
ROE -0.59%
ROIC N/A
ROA(3y)-0.84%
ROA(5y)-2.48%
ROE(3y)-3.08%
ROE(5y)-8.55%
ROIC(3y)N/A
ROIC(5y)N/A
CRWD Yearly ROA, ROE, ROICCRWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

1.3 Margins

Looking at the Gross Margin, with a value of 74.92%, CRWD is in the better half of the industry, outperforming 66.78% of the companies in the same industry.
In the last couple of years the Gross Margin of CRWD has remained more or less at the same level.
CRWD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.59%
GM growth 5Y1.2%
CRWD Yearly Profit, Operating, Gross MarginsCRWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150 -200

6

2. Health

2.1 Basic Checks

CRWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CRWD has been increased compared to 1 year ago.
Compared to 5 years ago, CRWD has more shares outstanding
Compared to 1 year ago, CRWD has an improved debt to assets ratio.
CRWD Yearly Shares OutstandingCRWD Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CRWD Yearly Total Debt VS Total AssetsCRWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 10.90 indicates that CRWD is not in any danger for bankruptcy at the moment.
The Altman-Z score of CRWD (10.90) is better than 88.34% of its industry peers.
The Debt to FCF ratio of CRWD is 0.70, which is an excellent value as it means it would take CRWD, only 0.70 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CRWD (0.70) is better than 74.20% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that CRWD is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.23, CRWD perfoms like the industry average, outperforming 44.52% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 0.7
Altman-Z 10.9
ROIC/WACCN/A
WACC10.87%
CRWD Yearly LT Debt VS Equity VS FCFCRWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

CRWD has a Current Ratio of 1.77. This is a normal value and indicates that CRWD is financially healthy and should not expect problems in meeting its short term obligations.
CRWD has a Current ratio (1.77) which is comparable to the rest of the industry.
CRWD has a Quick Ratio of 1.77. This is a normal value and indicates that CRWD is financially healthy and should not expect problems in meeting its short term obligations.
CRWD's Quick ratio of 1.77 is in line compared to the rest of the industry. CRWD outperforms 54.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.77
CRWD Yearly Current Assets VS Current LiabilitesCRWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

9

3. Growth

3.1 Past

CRWD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.60%, which is quite impressive.
The Earnings Per Share has been growing by 79.46% on average over the past years. This is a very strong growth
Looking at the last year, CRWD shows a very strong growth in Revenue. The Revenue has grown by 29.39%.
The Revenue has been growing by 52.37% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)27.6%
EPS 3Y79.46%
EPS 5YN/A
EPS Q2Q%8.42%
Revenue 1Y (TTM)29.39%
Revenue growth 3Y39.65%
Revenue growth 5Y52.37%
Sales Q2Q%25.22%

3.2 Future

The Earnings Per Share is expected to grow by 17.93% on average over the next years. This is quite good.
The Revenue is expected to grow by 22.02% on average over the next years. This is a very strong growth
EPS Next Y-11.13%
EPS Next 2Y8.95%
EPS Next 3Y16.99%
EPS Next 5Y17.93%
Revenue Next Year21.73%
Revenue Next 2Y21.68%
Revenue Next 3Y23.35%
Revenue Next 5Y22.02%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CRWD Yearly Revenue VS EstimatesCRWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
CRWD Yearly EPS VS EstimatesCRWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10 15 20

2

4. Valuation

4.1 Price/Earnings Ratio

CRWD is valuated quite expensively with a Price/Earnings ratio of 95.58.
CRWD's Price/Earnings is on the same level as the industry average.
CRWD is valuated expensively when we compare the Price/Earnings ratio to 28.29, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 107.54, the valuation of CRWD can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CRWD is on the same level as its industry peers.
CRWD is valuated expensively when we compare the Price/Forward Earnings ratio to 21.08, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 95.58
Fwd PE 107.54
CRWD Price Earnings VS Forward Price EarningsCRWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CRWD.
The rest of the industry has a similar Price/Free Cash Flow ratio as CRWD.
Industry RankSector Rank
P/FCF 87.18
EV/EBITDA 930.37
CRWD Per share dataCRWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

CRWD's earnings are expected to grow with 16.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.95%
EPS Next 3Y16.99%

0

5. Dividend

5.1 Amount

No dividends for CRWD!.
Industry RankSector Rank
Dividend Yield N/A

CROWDSTRIKE HOLDINGS INC - A

NASDAQ:CRWD (4/17/2025, 8:10:59 PM)

After market: 376 +0.38 (+0.1%)

375.62

-4.22 (-1.11%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-04 2025-03-04/amc
Earnings (Next)06-02 2025-06-02/amc
Inst Owners72.36%
Inst Owner Change0.01%
Ins Owners1.5%
Ins Owner Change35.7%
Market Cap93.10B
Analysts80.71
Price Target410.26 (9.22%)
Short Float %3.69%
Short Ratio2.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.79%
Min EPS beat(2)12.96%
Max EPS beat(2)18.62%
EPS beat(4)4
Avg EPS beat(4)9.65%
Min EPS beat(4)1.99%
Max EPS beat(4)18.62%
EPS beat(8)8
Avg EPS beat(8)12.6%
EPS beat(12)12
Avg EPS beat(12)16.15%
EPS beat(16)16
Avg EPS beat(16)25.73%
Revenue beat(2)2
Avg Revenue beat(2)0.67%
Min Revenue beat(2)0.53%
Max Revenue beat(2)0.82%
Revenue beat(4)2
Avg Revenue beat(4)-0.07%
Min Revenue beat(4)-1.42%
Max Revenue beat(4)0.82%
Revenue beat(8)3
Avg Revenue beat(8)-0.36%
Revenue beat(12)5
Avg Revenue beat(12)0.12%
Revenue beat(16)9
Avg Revenue beat(16)0.69%
PT rev (1m)-0.08%
PT rev (3m)6.28%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-30.39%
EPS NY rev (1m)-22.03%
EPS NY rev (3m)-21.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.27%
Revenue NY rev (1m)0.31%
Revenue NY rev (3m)0.37%
Valuation
Industry RankSector Rank
PE 95.58
Fwd PE 107.54
P/S 23.55
P/FCF 87.18
P/OCF 67.38
P/B 28.39
P/tB 41.68
EV/EBITDA 930.37
EPS(TTM)3.93
EY1.05%
EPS(NY)3.49
Fwd EY0.93%
FCF(TTM)4.31
FCFY1.15%
OCF(TTM)5.57
OCFY1.48%
SpS15.95
BVpS13.23
TBVpS9.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.22%
ROE -0.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.92%
FCFM 27.01%
ROA(3y)-0.84%
ROA(5y)-2.48%
ROE(3y)-3.08%
ROE(5y)-8.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.59%
GM growth 5Y1.2%
F-Score4
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 0.7
Debt/EBITDA 7.73
Cap/Depr 146.68%
Cap/Sales 7.94%
Interest Coverage N/A
Cash Conversion 1435.92%
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 1.77
Altman-Z 10.9
F-Score4
WACC10.87%
ROIC/WACCN/A
Cap/Depr(3y)197.98%
Cap/Depr(5y)189.47%
Cap/Sales(3y)9.19%
Cap/Sales(5y)8.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.6%
EPS 3Y79.46%
EPS 5YN/A
EPS Q2Q%8.42%
EPS Next Y-11.13%
EPS Next 2Y8.95%
EPS Next 3Y16.99%
EPS Next 5Y17.93%
Revenue 1Y (TTM)29.39%
Revenue growth 3Y39.65%
Revenue growth 5Y52.37%
Sales Q2Q%25.22%
Revenue Next Year21.73%
Revenue Next 2Y21.68%
Revenue Next 3Y23.35%
Revenue Next 5Y22.02%
EBIT growth 1Y-19489%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year44.3%
EBIT Next 3Y36.43%
EBIT Next 5YN/A
FCF growth 1Y14.94%
FCF growth 3Y34.28%
FCF growth 5Y143.79%
OCF growth 1Y18.48%
OCF growth 3Y33.96%
OCF growth 5Y69.11%